Dianne M. Nast enjoys a national complex litigation practice in antitrust, product liability, personal injury and other complex civil litigation. By way of example, she was sole Lead Counsel for the direct purchaser class in Wellbutrin SR Antitrust Litigation, Eastern District of Pennsylvania and Augmentin Antitrust Litigation, Eastern District of Virginia. She was Co-Lead Counsel in Paxil Class Antitrust Litigation, Eastern District of Pennsylvania, in the HIV Class Litigation, MDL No. 986, Northern District of Illinois and a member of the Plaintiffs’ Steering Committee (“PSC”) and subclass counsel in Diet Drugs, MDL No. 1203, Eastern District of Pennsylvania. Nast serves in leadership roles in multiple other complex class action cases such as on the PSCs in both Effexor Antitrust Litigation, District of New Jersey and NFL Injury Litigation, MDL No. 2323, Eastern District of Pennsylvania, and on the PSC and as Mediation Counsel in Skelaxin Antitrust Litigation, MDL No. 2343, Eastern District of Tennessee.
In the non-class, aggregate litigation context, again by way of example, Nast is Lead Counsel in Zoloft Litigation, MDL No. 2343, Eastern District of Pennsylvania and Co-Lead Counsel in the Darvocet Litigation, MDL No. 2226, Eastern District of Kentucky. She is on the PSC and chairs the Fee Committee in the Avandia Litigation, MDL No. 1871, Eastern District of Pennsylvania, and is Federal-State Liaison and a member of the Policy Committee. Nast is Federal-State Liaison Counsel in the Yaz Litigation, MDL No. 2100, Southern District of Illinois. She is a Co-Lead in the state court Yaz cases in Pennsylvania. She currently serves on the PSC in Actos Litigation, MDL No. 2299, Western District of Louisiana, in Pelvic Repair Systems Litigations, MDL Nos. 2187, 2325, 2326, 2327 and 2387, Southern District of West Virginia, and in the Mirena IUD Litigation, MDL No. 2434, Southern District of New York.
